8-K filed February 26, 2026, 6:59 PM ET ticker BSX CIK 0000885725

debt confidence high sentiment positive materiality 0.80

Boston Scientific enters $11B credit facilities; $8B committed for Penumbra acquisition

BOSTON SCIENTIFIC CORP

$3.0B revolving credit agreement matures Feb 2031 with two one-year extension options.
$2.0B 364-day revolving credit agreement tied to Penumbra acquisition; matures 364 days post-close.
$6.0B term loan agreement: $1B Tranche A and $5B Tranche B, both 364-day delayed draw at closing.
Tranche B Loans must be prepaid with net proceeds from equity or debt issuance after closing.
Prior $3.0B 2021 revolving credit agreement terminated upon entry into the new facilities.

item 1.01 item 1.02 item 2.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000885725-26-000017
form_type: 8-K
ticker: BSX
cik: 0000885725
company_name: BOSTON SCIENTIFIC CORP
filed_at: 2026-02-26T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.920404+00:00
generated_at: 2026-05-15T23:58:55.744773+00:00
sec_items: ["1.01", "1.02", "2.03", "9.01"]
event_type: debt
sentiment: positive
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000885725-26-000017
json_url: https://secwatch.observer/filing/0000885725-26-000017.json
markdown_url: https://secwatch.observer/filing/0000885725-26-000017.md
text_url: https://secwatch.observer/filing/0000885725-26-000017.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/885725/000088572526000017/0000885725-26-000017-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/885725/000088572526000017/bsx-20260226.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

6b02d2bb1d4041edb26beea72b50e2b1cd37e5e9

BOSTON SCIENTIFIC CORP incurred revolving credit of $2.000 billion with Wells Fargo Bank, National Association at Term SOFR determined for the interest period plus the applicable margin based on maturing the date that is 364 days from the earlier of (i) the date that any loans under the 364-Day Revolving Credit Agreement are available to be drawn on, or (ii) the.

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

SEC 8-K Item 2.03/2.04 confidence 0.9 SEC evidence

b2b72c8d064bd3714f2906972843af0af86794a1

BOSTON SCIENTIFIC CORP incurred term loan of up to $1.000 billion with Wells Fargo Bank, National Association maturing 364-day delayed draw.

by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent. Under the Term Loan Credit Agreement, the Company may borrow (i) a 364-day delayed draw term loan in an aggregate principal amount of up to $1.000 billion

SEC 8-K Item 2.03/2.04 confidence 0.9 SEC evidence

f23861177ed910752b79ccd99339eb73507b1df9

BOSTON SCIENTIFIC CORP incurred revolving credit of $3.000 billion with Wells Fargo Bank, National Association at Term SOFR determined for the interest period plus the applicable margin based on maturing February 26, 2031.

On February 26, 2026, Boston Scientific Corporation (the “ Company ”) entered into a $3.000 billion revolving credit agreement (the “ 2026 Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

SEC 8-K Item 2.03/2.04 confidence 0.9 SEC evidence

21aa53e153eb94742e70c9f054af419686f8d145

BOSTON SCIENTIFIC CORP entered into 364-Day Revolving Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the several lenders party thereto valued at $2.000 billion (effective 2026-02-26).

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

cba15c69bc86aed9a8628112bb3638d7b70f3907

BOSTON SCIENTIFIC CORP entered into 2026 Revolving Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the several lenders party thereto valued at $3.000 billion (effective 2026-02-26).

On February 26, 2026, Boston Scientific Corporation (the “ Company ”) entered into a $3.000 billion revolving credit agreement (the “ 2026 Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

de86295b027db259ccec970b085f612a8d04903d

BOSTON SCIENTIFIC CORP entered into Term Loan Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the several lenders party thereto valued at $6.000 billion (effective 2026-02-26).

On February 26, 2026, the Company entered into a $6.000 billion term loan credit agreement (the “ Term Loan Credit Agreement ” and together with the 2026 Revolving Credit Agreement and the 364-Day Revolving Credit Agreement, the “ 2026 Credit Agreements ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

ILPT

ILPT Mountain JV closes $1.62B loan at 5.71% fixed, repays $1.6B existing debt

Industrial Logistics Properties Trust May 8, 2026, 7:59 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 1.02, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively, the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured by 90 of its properties, or the Loan . Also on May 8, 2026, we entered into a guaranty in favor of the lenders, pursuant to which we guaranteed certain limited

Filing page SEC filing

EMAT

EMAT secures $100M convertible debenture facility from Yorkville; first $20M tranche issued

Evolution Metals & Technologies Corp. May 11, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 7.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

The first Convertible Debenture (the “First Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026.

Filing page SEC filing

TBH

Brag House issues $2.5M convertible notes at 25% OID; proceeds for House of Doge merger

Brag House Holdings, Inc. May 8, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

The issuance of the Notes in the aggregate original principal amount of $2,500,000 constitutes the creation of a direct financial obligation of the Company. The Notes bear interest at 12.0% per annum, mature on February 4, 2027

Filing page SEC filing

KNX

Knight-Swift closes $1.5B convertible note offering at 1.00% due 2031; proceeds used to repay term loans and revolver

Knight-Swift Transportation Holdings Inc. May 8, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 8.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

On May 8, 2026, Knight-Swift Transportation Holdings Inc. (the "Company") completed its previously announced private offering (the "Offering") of $1.5 billion aggregate principal amount of 1.00% Convertible Senior Notes due 2031

Filing page SEC filing

MDLN

Medline issues $2.0B senior secured notes & refinances $2.75B term loan; secondary offering of 72.6M shares at $37

Medline Inc. June 2, 2026, 8:06 AM ET debt Items 1.01, 2.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

Concurrently with the Notes offering, the Issuer refinanced its existing senior secured dollar-denominated term loan facility due 2030 (the “ 2030 Term Loan Facility ”) with a new senior secured dollar-denominated term loan facility in an aggregate principal amount of approximately $2,750.0 million (the “ 2033 Refinancing Term Loan Facility ” and, together with the existing revolving credit facility, the “ Senior Secured Credit Facilities ”).

Filing page SEC filing

TSEOF

Trinseo obtains $142.5M new money DIP financing and $150M AR facility in Chapter 11

Trinseo PLC June 1, 2026, 4:23 PM ET debt Items 1.01, 2.03, 9.01

same fact type: material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

On May 28, 2026, the Company, as parent, Trinseo NA Finance LLC, as holdings, Trinseo Luxco Finance SPV S.à r.l. and Trinseo NA Finance SPV LLC (together, the “ SHC Borrowers ”), as borrowers, the guarantors party thereto from time to time, the lenders party thereto from time to time (the “ SHC DIP Lenders ”), and Alter Domus (US) LLC, as administrative agent and collateral agent, entered into a Senior Secured Super-Priority Debtor-In-Possession HoldCo Credit Agreement (the “ Super-Holdco DIP Credit Agreement ”), providing for a senior secured super-priority priming term loan debtor-in-possession credit facility in an aggregate principal amount of $157.5 million (the “ Super-Holdco DIP Facility ”).

Filing page SEC filing

SST

System1 exchanges $302.6M debt for $150M term loan, $39.3M preferred stock, and cash

System1, Inc. June 1, 2026, 9:00 AM ET debt Items 1.01, 2.03, 3.02, 7.01, 9.01

same fact type: debt_financing same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

specified in the Exchange Agreement on the terms and subject to the conditions set forth therein. The consideration under the Exchange Agreement consists of (i) a new $150.0 million term loan facility held by the Participating Lenders (the “Priority Term Loans”), (ii) the issuance of 39,250 shares of Series A Cumulative Convertible Preferred Stock (the

Filing page SEC filing

CNMD

CONMED secures $450M incremental term loan facility to repurchase convertible notes due 2026

CONMED Corp June 1, 2026, 8:31 AM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On February 26, 2026, the Company entered into a $2.000 billion 364-day revolving credit agreement (the “ 364-Day Revolving Credit Agreement ”) by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.

Comparable filing

CONMED entered into the First Amendment to, among other things, obtain commitments for incremental senior secured delayed draw term “a” loans available in U.S. dollars to CONMED in an aggregate principal amount equal to $450 million (the “ Term A-2 Loan Facility ”), which is available to be borrowed in a single drawing on or prior to June 14, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0000885725-26-000017

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.